The Beauty Health Company SKIN Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect at other companies
Other financials
Where this comes from
Reported directly by The Beauty Health Company in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Beauty Health Company's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Beauty Health Company's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect?
- The Beauty Health Company (SKIN) reported cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect of -$28.11M in Q1 2026.
- How has The Beauty Health Company's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect changed year-over-year?
- The Beauty Health Company's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect decreased by 1855.7% year-over-year, from $1.6M to -$28.11M.
- What does cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect mean?
- Measures the net change in the company's total liquid assets, including cash, cash equivalents, and restricted cash, over a specific period. This is a primary indicator of the company's overall cash flow health and liquidity position.